The stock of Adicet Bio Inc (ACET) has seen a -8.97% decrease in the past week, with a 17.29% gain in the past month, and a -36.81% decrease in the past quarter. The volatility ratio for the week is 15.14%, and the volatility levels for the past 30 days are at 11.34% for ACET. The simple moving average for the past 20 days is 3.43% for ACET’s stock, with a -43.47% simple moving average for the past 200 days.
Is It Worth Investing in Adicet Bio Inc (NASDAQ: ACET) Right Now?
Additionally, the 36-month beta value for ACET is 1.66. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for ACET is 65.38M and currently, short sellers hold a 3.12% ratio of that float. The average trading volume of ACET on May 12, 2025 was 445.27K shares.
ACET) stock’s latest price update
Adicet Bio Inc (NASDAQ: ACET) has experienced a rise in its stock price by 27.49 compared to its previous closing price of 0.48. However, the company has seen a fall of -8.97% in its stock price over the last five trading days. zacks.com reported 2025-05-09 that Adicet Bio (ACET) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Analysts’ Opinion of ACET
Many brokerage firms have already submitted their reports for ACET stocks, with Guggenheim repeating the rating for ACET by listing it as a “Buy.” The predicted price for ACET in the upcoming period, according to Guggenheim is $7 based on the research report published on September 30, 2024 of the previous year 2024.
ACET Trading at -12.37% from the 50-Day Moving Average
After a stumble in the market that brought ACET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.75% of loss for the given period.
Volatility was left at 11.34%, however, over the last 30 days, the volatility rate increased by 15.14%, as shares surge +36.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.05% lower at present.
During the last 5 trading sessions, ACET fell by -8.97%, which changed the moving average for the period of 200-days by -57.65% in comparison to the 20-day moving average, which settled at $0.5895. In addition, Adicet Bio Inc saw -36.60% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ACET starting from Kauffman Michael, who sale 5,900 shares at the price of $1.43 back on Jun 05 ’24. After this action, Kauffman Michael now owns 5,900 shares of Adicet Bio Inc, valued at $8,437 using the latest closing price.
Stock Fundamentals for ACET
The total capital return value is set at -0.64. Equity return is now at value -55.83, with -48.44 for asset returns.
Based on Adicet Bio Inc (ACET), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -5.36. The debt to equity ratio resting at 0.09. The interest coverage ratio of the stock is -31904.0.
Currently, EBITDA for the company is -127.61 million with net debt to EBITDA at 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.34.
Conclusion
In conclusion, Adicet Bio Inc (ACET) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
